trending Market Intelligence /marketintelligence/en/news-insights/trending/b-OAKhDFc7cAkfc9p6OILg2 content esgSubNav
In This List

Inovalon Holdings teams up with biotech company Amgen

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Inovalon Holdings teams up with biotech company Amgen

Inovalon Holdings Inc. has inked an agreement with Amgen Inc. to target value-based contracts between payers and life sciences companies.

Under the pact, Inovalon and its wholly owned subsidiary, Avalere Health, will use their data and analytics to further develop outcome-based contracts based on the value of Amgen's products. They will specifically work on rheumatoid arthritis, a chronic, high-cost autoimmune disease affecting more than two million Americans.